These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29680411)

  • 41. Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.
    Rasche M; von Neuhoff C; Dworzak M; Bourquin JP; Bradtke J; Göhring G; Escherich G; Fleischhack G; Graf N; Gruhn B; Haas OA; Klingebiel T; Kremens B; Lehrnbecher T; von Stackelberg A; Tchinda J; Zemanova Z; Thiede C; von Neuhoff N; Zimmermann M; Creutzig U; Reinhardt D
    Leukemia; 2017 Dec; 31(12):2807-2814. PubMed ID: 28443606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cytogenetic model predicts relapse risk and survival in patients with acute myeloid leukemia undergoing hematopoietic stem cell transplantation in morphologic complete remission.
    Rashidi A; Cashen AF
    Leuk Res; 2015 Jan; 39(1):77-81. PubMed ID: 25481050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different prognostic effects of core-binding factor positive AML with Korean AML registry data.
    Shin HJ; Min WS; Min YH; Cheong JW; Lee JH; Kim IH; Hong DS; Ahn JS; Kim HJ; Lee WS; Jung CW; Jang JH; Park Y; Kim HJ;
    Ann Hematol; 2019 May; 98(5):1135-1147. PubMed ID: 30758645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new prognostic score for patients with acute myeloid leukemia based on cytogenetics and early blast clearance in trials of the German AML Cooperative Group.
    Haferlach T; Kern W; Schoch C; Schnittger S; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
    Haematologica; 2004 Apr; 89(4):408-18. PubMed ID: 15075074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
    Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
    J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and prognostic significance of eosinophilia and inv(16)/t(16;16) in pediatric acute myelomonocytic leukemia (AML-M4).
    Klein K; de Haas V; Bank IEM; Beverloo HB; Zwaan CM; Kaspers GL
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
    Marcucci G; Mrózek K; Ruppert AS; Archer KJ; Pettenati MJ; Heerema NA; Carroll AJ; Koduru PR; Kolitz JE; Sterling LJ; Edwards CG; Anastasi J; Larson RA; Bloomfield CD
    J Clin Oncol; 2004 Jun; 22(12):2410-8. PubMed ID: 15197203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
    Schoch C; Haase D; Haferlach T; Gudat H; Büchner T; Freund M; Link H; Lengfelder E; Wandt H; Sauerland MC; Löffler H; Fonatsch C
    Leukemia; 1996 Aug; 10(8):1288-95. PubMed ID: 8709633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A long-term follow-up study of 82 children with acute myeloid leukemia].
    Ruan M; Qi BQ; Liu F; Liu TF; Liu XM; Chen XJ; Yang WY; Guo Y; Zhang L; Zou Y; Chen YM; Zhu XF
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):730-734. PubMed ID: 30293275
    [No Abstract]   [Full Text] [Related]  

  • 53. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.
    Schweitzer J; Zimmermann M; Rasche M; von Neuhoff C; Creutzig U; Dworzak M; Reinhardt D; Klusmann JH
    Ann Hematol; 2015 Aug; 94(8):1327-36. PubMed ID: 25913479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.
    Grosicki S; Holowiecki J; Kuliczkowski K; Skotnicki A; Hellmann A; Kyrcz-Krzemien S; Dmoszynska A; Sułek K; Kloczko J; Jedrzejczak WW; Warzocha K; Zdziarska B; Wierzbowska A; Pluta A; Komarnicki M; Giebel S
    Am J Hematol; 2015 Oct; 90(10):904-9. PubMed ID: 26149802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute myeloid leukaemia: expression of MYC protein and its association with cytogenetic risk profile and overall survival.
    Mughal MK; Akhter A; Street L; Pournazari P; Shabani-Rad MT; Mansoor A
    Hematol Oncol; 2017 Sep; 35(3):350-356. PubMed ID: 26856970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
    Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
    Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: a comprehensive large-scale study from a single Chinese center.
    Qin YZ; Zhu HH; Jiang Q; Jiang H; Zhang LP; Xu LP; Wang Y; Liu YR; Lai YY; Shi HX; Jiang B; Huang XJ
    Leuk Res; 2014 Dec; 38(12):1435-40. PubMed ID: 25449688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Characteristics and Treatment Outcomes of Myeloid Sarcoma in Children: The Experience of the Polish Pediatric Leukemia and Lymphoma Study Group.
    Samborska M; Barańska M; Wachowiak J; Skalska-Sadowska J; Thambyrajah S; Czogała M; Balwierz W; Kołtan S; Peszyńska-Żelazny K; Wysocki M; Ociepa T; Urasiński T; Wróbel G; Węcławek-Tompol J; Ukielska B; Chybicka A; Kitszel A; Krawczuk-Rybak M; Szmydki-Baran A; Malinowska I; Matysiak M; Mizia-Malarz A; Tomaszewska R; Szczepański T; Chodała-Grzywacz A; Karolczyk G; Maciejka-Kembłowska L; Irga-Jaworska N; Badowska W; Dopierała M; Kurzawa P; Derwich K
    Front Oncol; 2022; 12():935373. PubMed ID: 35875115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel.
    Stark B; Jeison M; Gabay LG; Mardoukh J; Luria D; Bar-Am I; Avrahami G; Kapeliushnik Y; Sthoeger D; Herzel G; Steinberg DM; Cohen IJ; Goshen Y; Stein J; Zaizov R; Yaniv I
    Br J Haematol; 2004 Aug; 126(3):320-37. PubMed ID: 15257704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Translocation t(9;11)(p21;q23) in pediatric de novo and secondary acute myeloblastic leukemia.
    Sandoval C; Head DR; Mirro J; Behm FG; Ayers GD; Raimondi SC
    Leukemia; 1992 Jun; 6(6):513-9. PubMed ID: 1602790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.